Proteus Insights offers strategic consulting services on the full range of issues involved in commercializing Regenerative Medicine (RM) technologies. Our clients include emerging RM companies, Pharma and Biotech companies, non-profit organizations, medical centers, and government agencies. Proteus has access to a worldwide network of industry, academic, and governmental resources.

The Firm has built extensive proprietary databases covering RM companies and products worldwide, major academic programs, and dominant intellectual property portfolios. We have developed sophisticated financial models designed specifically for making valuation and resource allocation decisions involving RM products, platforms, and emerging companies.